Literature DB >> 21785051

Value of PET/CT in the management of primary hepatobiliary tumors, part 2.

Ari Sacks1, Patrick J Peller, Devaki S Surasi, Luke Chatburn, Gustavo Mercier, Rathan M Subramaniam.   

Abstract

OBJECTIVE: Primary hepatobiliary malignancies consist of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. Benign hepatic lesions include hepatic cysts, hemagiomas, adenomas, and focal nodular hyperplasias. The utility of PET/CT in imaging primary hepatobiliary lesions varies according to the type and location of the lesion.
CONCLUSION: There is a consistent benefit to the use of PET/CT for detection and staging, and it ultimately helps to establish the best course of treatment and to determine prognosis. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for hepatobiliary malignancies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785051     DOI: 10.2214/AJR.11.6995

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

Review 1.  Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.

Authors:  Ana F Brito; Mónica Mendes; Ana M Abrantes; José G Tralhão; Maria F Botelho
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

2.  Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.

Authors:  Vikas Gupta; K S Vishnu; Thakur D Yadav; Yashwant R Sakaray; Santosh Irrinki; B R Mittal; N Kalra; K Vaiphei
Journal:  J Gastrointest Cancer       Date:  2019-12

3.  Circulating tumor cells in biliary cancer: First step or false step?

Authors:  G Thomas Budd
Journal:  J Gastrointest Oncol       Date:  2012-06

4.  Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.

Authors:  Darryl Lim; Ser Yee Lee; Kiat Hon Lim; Chung Yip Chan
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

Review 5.  Modern perspectives on factors predisposing to the development of gallbladder cancer.

Authors:  Charles H C Pilgrim; Ryan T Groeschl; Kathleen K Christians; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

Review 6.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Christine H Chung; Jeremy Richmon; Wayne Koch; Harry Quon; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

8.  PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.

Authors:  Ser Yee Lee; T Peter Kingham; Maria D LaGratta; Jose Jessurun; Daniel Cherqui; William R Jarnagin; Michael D Kluger
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

9.  Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time.

Authors:  Alin Chirindel; Krishna C Alluri; Abdel K Tahari; Muhammad Chaudhry; Richard L Wahl; Martin A Lodge; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2015-01       Impact factor: 7.794

Review 10.  FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Nobuyuki Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-03       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.